Paragon 28, Inc. (NYSE:FNA – Get Free Report) major shareholder Mvm Partners, Llc sold 10,835 shares of the stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $10.09, for a total transaction of $109,325.15. Following the completion of the sale, the insider now directly owns 10,548,230 shares in the company, valued at $106,431,640.70. This trade represents a 0.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
Mvm Partners, Llc also recently made the following trade(s):
- On Friday, November 22nd, Mvm Partners, Llc sold 72,133 shares of Paragon 28 stock. The shares were sold at an average price of $10.16, for a total transaction of $732,871.28.
- On Wednesday, November 20th, Mvm Partners, Llc sold 147,581 shares of Paragon 28 stock. The stock was sold at an average price of $10.28, for a total transaction of $1,517,132.68.
Paragon 28 Stock Performance
FNA opened at $9.99 on Thursday. The firm has a 50 day moving average of $6.89 and a two-hundred day moving average of $7.26. The firm has a market capitalization of $836.36 million, a PE ratio of -13.50 and a beta of 1.01. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79. Paragon 28, Inc. has a 12-month low of $4.65 and a 12-month high of $14.79.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on FNA shares. Piper Sandler reaffirmed an “overweight” rating and set a $12.00 target price (down from $15.00) on shares of Paragon 28 in a research report on Friday, August 9th. Canaccord Genuity Group decreased their price objective on shares of Paragon 28 from $17.00 to $15.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Finally, Needham & Company LLC upped their price target on shares of Paragon 28 from $11.00 to $13.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $15.60.
Check Out Our Latest Stock Report on Paragon 28
Institutional Trading of Paragon 28
Several hedge funds and other institutional investors have recently bought and sold shares of FNA. Barclays PLC boosted its position in Paragon 28 by 180.6% in the 3rd quarter. Barclays PLC now owns 84,812 shares of the company’s stock worth $567,000 after purchasing an additional 54,591 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Paragon 28 by 2.5% in the third quarter. Geode Capital Management LLC now owns 967,519 shares of the company’s stock worth $6,464,000 after acquiring an additional 23,167 shares during the period. Wellington Management Group LLP boosted its stake in shares of Paragon 28 by 7.0% during the 3rd quarter. Wellington Management Group LLP now owns 694,799 shares of the company’s stock worth $4,641,000 after acquiring an additional 45,215 shares in the last quarter. State Street Corp grew its position in shares of Paragon 28 by 2.6% during the 3rd quarter. State Street Corp now owns 1,563,331 shares of the company’s stock valued at $10,443,000 after acquiring an additional 39,075 shares during the period. Finally, Stonepine Capital Management LLC purchased a new position in shares of Paragon 28 in the 3rd quarter valued at about $766,000. 63.57% of the stock is owned by institutional investors and hedge funds.
About Paragon 28
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Featured Articles
- Five stocks we like better than Paragon 28
- The Risks of Owning Bonds
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Want to Profit on the Downtrend? Downtrends, Explained.
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.